Author Correction: Epithelial TGFβ engages growth-factor signalling to circumvent apoptosis and drive intestinal tumourigenesis with aggressive features
Nat Commun. 2023 Jan 31;14(1):522.
doi: 10.1038/s41467-023-36266-w.
1 Cancer Research UK Beatson Institute, Glasgow, UK. [email protected].
2 Department of Biochemistry and Molecular Biology, Monash University, Melbourne, Australia. [email protected].
3 Cancer Program, Biomedicine Discovery Institute, Monash University, Melbourne, Australia. [email protected].
4 The Patrick G. Johnston Centre for Cancer Research, Queen's University Belfast, Belfast, UK.
5 Cancer Research UK Beatson Institute, Glasgow, UK.
6 Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, UK.
7 Department of Molecular Pathology, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
8 Institute of Cancer Sciences, University of Glasgow, Glasgow, UK.
9 Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH) and Deutsches Krebsforschungszentrum (DKFZ), Heidelberg, Germany.
10 Department of Oncology, University of Torino, Candiolo, Torino, Italy.
11 University of Newcastle upon Tyne, Newcastle, UK.
12 INSERM Centre de Recherche en Cancérologie de Lyon, Lyon, France.
13 GE Global Research Center, Niskayuna, NY, USA.
14 Centre for Public Health, Queen's University Belfast, Belfast, UK.
15 Department of Cellular Pathology, Belfast Health and Social Care Trust, Belfast, UK.
16 CRUK/MRC Oxford Institute for Radiation Oncology, University of Oxford, Oxford, UK.